Notice of Clarification to Eligibility Information in PAR-19-349 "NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)"

Notice Number: NOT-CA-19-069

Key Dates
Release Date: August 28, 2019

Related Announcements
PAR-19-349

Issued by
National Cancer Institute (NCI)

Purpose

This Notice corrects and clarifies the Eligibility Information in PAR-19-349 "NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)".

Part 2. Full Text of Announcement; Section III. Eligibility Information

Currently reads:

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

Should correctly read (in italics)

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

Only single PD/PI applications are allowed. Applications with multiple PD(s)/PI(s) will not be accepted.

Inquiries

Please direct all inquiries to:

Christine Siemon
National Cancer Institute (NCI)
Telephone: 240-276-6180
Email: siemonc@mail.nih.gov